MDRl/P-Glycoprotein Overexpression in Bladder Transitional Cell Carcinoma and its Correlation with Expression of Survivin and Fas

References

1. ↵
   1. Landis SH,
   2. Murray T,
   3. Bolden S, et al

   . Cancer statistics. CA Cancer J Clin. l999;49:8–31.
2. ↵
   1. McKnight JJ,
   2. Gray SB,
   3. O'Kane HF, et al

   . Apoptosis and chemotherapy for bladder cancer. J Urol. 2005;173:683–690.

   OpenUrlCrossRefPubMedWeb of Science
3. ↵
   1. Friedrich K,
   2. Wieder T,
   3. Von Haefen C, et al

   . Overexpression of caspase -3 restores sensitivity for drug -induced apoptosis in breast cancer cell lines with acquired drug resistance. Oncogene. 2001;20:2749–2760.

   OpenUrlCrossRefPubMedWeb of Science
4. ↵
   1. Radetzki S,
   2. Kohne CH,
   3. von Haefen C, et al

   . The apoptosis promoting Bcl-2 homologues Bak and Nbk/Bik overcome drug resistance in Mdr-1-negative and Mdr-1-overexpressing breast cancer cell lines. Oncogene. 2002;21:227–238.

   OpenUrlCrossRefPubMed
5. ↵
   1. Hasegawa S,
   2. Abe T,
   3. Naito S, et al

   . Expression of multidrug resistance-associated protein (MRP), MDR1 and DNA topoisomerase II in human multidrug-resistant bladder cancer cell lines. Br J Cancer. 1995;71:907–913.

   OpenUrlCrossRefPubMedWeb of Science
6. ↵
   1. Nakagawa M,
   2. Emoto A,
   3. Nasu N, et al

   . Clinical significance of multi-drug resistance associated protein and P-glycoprotein in patients with bladder cancer. J Urol. 1997;157:1260–1265.

   OpenUrlCrossRefPubMedWeb of Science
7. ↵
   1. Cao L,
   2. Duchrow M,
   3. Windhovel U, et al

   . Expression of MDR1 mRNA and encoding P-glycoprotein in archival formalin-fixed paraffin-embedded gall bladder cancer tissues. Eur J Cancer. 1998;34:1612–1617.

   OpenUrlPubMed
8. ↵
   1. Tada Y,
   2. Wada M,
   3. Migita T, et al

   . Increased expression of multidrug resistance-associated proteins in bladder cancer during clinical course and drug resistance to doxorubicin. Int J Cancer. 2002;98:630–635.

   OpenUrlCrossRefPubMed
9. ↵
   1. Yuan JL,
   2. Wang H,
   3. Wang PF, et al

   . Expression of P-glycoprotein in transitional cell carcinoma of urinary bladder and its significance in tumor recurrence. Journal of Third Military Medical University (Chinese). 2000;22:1176–1178.

   OpenUrl
10. ↵
    1. Yakirevich E,
    2. Sabo E,
    3. Naroditsky I, et al

    . Multidrug resistance-related phenotype and apoptosis-related protein expression in ovarian serous carcinomas. Gynecol Oncol. 2006;100:152–159.

    OpenUrlCrossRefPubMed
11. ↵
    1. Sagol O,
    2. Yavuzsen T,
    3. Oztop I, et al

    . The effect of apoptotic activity, survivin, Ki-67, and P-glycoprotein expression on prognosis in pancreastic carcinoma. Pancreas. 2005;30:343–348.

    OpenUrlCrossRefPubMedWeb of Science
12. ↵
    1. Yin F,
    2. Shi YQ,
    3. Zhao B, et al

    . Suppression of P-gp induced multiple resistance in a drug resistant gastric cancer cell line by overexpression of Fas. World J Gastroenterol. 2000;6:664–670.

    OpenUrlPubMed